Acelyrin Inc. (SLRN) NASDAQ

$5.37 (0.39) (-6.77%)

Market Cap: $528.22M

As of 04/12/24 04:00 PM EDT. Market closed.

(SLRN)

Acelyrin Inc. (SLRN)
NASDAQ

$5.37
(0.39) (-6.77%)

Market Cap: $528.22M

As of 04/12/24 04:00 PM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
PRICE CHART FOR ACELYRIN INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.72
Previous Close
$5.76
Days Range
$5.34 - $5.71
52 week range
$5.34 - $29.88
Volume
489,507
Avg. Volume (30 days)
1,600,412
Market Cap
$528.22M
Dividend Yield
-
P/E
-
Shares Outstanding
98,365,050
Open
$5.72
Previous Close
$5.76
Days Range
$5.34 - $5.71
52 week range
$5.34 - $29.88
Volume
489,507
Avg. Volume (30 days)
1,600,412
Market Cap
$528.22M
Dividend Yield
-
P/E
-
Shares Outstanding
98,365,050
FINANCIAL STATEMENTS FOR ACELYRIN INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ACELYRIN INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Lin Shao-LeeChief Executive OfficerApr 01, 2024 Sale$6.639,96166,0241,577,374Apr 03, 2024, 06:18 PM
Lin Shao-LeeChief Executive OfficerFeb 20, 2024 Sale$7.6015,701119,4031,587,335Feb 22, 2024, 07:04 PM
Lin Shao-LeeChief Executive OfficerJan 02, 2024 Sale$7.4110,69179,1881,603,036Jan 04, 2024, 06:09 PM
Westlake BioPartners Fund II, L.P.10% OwnerMay 09, 2023 Buy$18.001,250,00022,500,0009,790,729May 11, 2023, 09:16 PM
SEIDENBERG BETH CDirectorMay 09, 2023 Buy$18.001,250,00022,500,0009,790,729May 11, 2023, 09:13 PM
SEIDENBERG BETH CDirectorMay 09, 2023 Buy$18.0060,0001,080,00060,000May 11, 2023, 09:13 PM
Svoronos DawnDirectorMay 09, 2023 Buy$18.0015,000270,00015,000May 11, 2023, 09:11 PM
Gosebruch Henry ODirectorMay 09, 2023 Buy$18.0050,000900,00050,000May 11, 2023, 09:06 PM
Becker Daniel J.DirectorMay 09, 2023 Buy$18.003,00054,0003,000May 11, 2023, 09:02 PM
Oyston RonaldChief People OfficerMay 09, 2023 Buy$18.002646826May 11, 2023, 09:00 PM
Oyston RonaldChief People OfficerMay 09, 2023 Buy$18.001,00018,0001,000May 11, 2023, 09:00 PM
Kim MinaChief Legal & Admin. OfficerMay 09, 2023 Buy$18.005,00090,0005,000May 11, 2023, 08:58 PM
Peloso PaulChief Medical OfficerMay 09, 2023 Buy$18.006,000108,0006,000May 11, 2023, 08:54 PM
Dier MardiCFO and CBOMay 09, 2023 Buy$18.001,75031,500875May 11, 2023, 08:51 PM
Dier MardiCFO and CBOMay 09, 2023 Buy$18.005,556100,0085,556May 11, 2023, 08:51 PM
Lin Shao-LeeChief Executive OfficerMay 09, 2023 Option Exercise$24.69337,1798,324,950770,034May 11, 2023, 08:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Lin Shao-LeeChief Executive Officer04/01/202466,024
Lin Shao-LeeChief Executive Officer02/20/2024119,403
Lin Shao-LeeChief Executive Officer01/02/202479,188
Westlake BioPartners Fund II, L.P.10% Owner05/09/202322,500,000
SEIDENBERG BETH CDirector05/09/202322,500,000
SEIDENBERG BETH CDirector05/09/20231,080,000
Svoronos DawnDirector05/09/2023270,000
Gosebruch Henry ODirector05/09/2023900,000
Becker Daniel J.Director05/09/202354,000
Oyston RonaldChief People Officer05/09/2023468
Oyston RonaldChief People Officer05/09/202318,000
Kim MinaChief Legal & Admin. Officer05/09/202390,000
Peloso PaulChief Medical Officer05/09/2023108,000
Dier MardiCFO and CBO05/09/202331,500
Dier MardiCFO and CBO05/09/2023100,008
Lin Shao-LeeChief Executive Officer05/09/20238,324,950
Load More Insider Transactions
FUNDS WITH A POSITION IN ACELYRIN INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC4,001,7110.6%-24.87%Other
BLACKROCK INC.2,907,5580.00055%32.27%Other
TYBOURNE CAPITAL MANAGEMENT (HK) LTD2,906,6293.23%30.32%Growth, Growth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC774,1310.0006%9.22%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.180,0000.00278%80%Other
ALPS ADVISORS INC64,6270.00379%NewOther
UBS OCONNOR LLC60,0000.03%NewValue
CHANGE IN SHARES OUTSTANDING FOR ACELYRIN INC
STOCK BUYBACKS FOR ACELYRIN INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
06/30/2023
7.73%
2Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
7.73%
2Q
BUYBACK ANNOUNCEMENT(S) FOR ACELYRIN INC
LOADING...